NCT04071652View on ClinicalTrials.gov

MATTERS Study - Mistral Percutaneous Tricuspid Valve Repair FIM Study

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 8, 2017

Primary Completion Date

October 1, 2020

Study Completion Date

February 28, 2023

Conditions
Tricuspid Valve Regurgitation
Interventions
DEVICE

Mistral implantation

Mistral implant is implanted in the Tricuspid valve

Trial Locations (3)

52621

The Chain Sheba Medical Center at Tel HaShomer, Ramat Gan

91120

Haddassah, Jerusalem

6423906

Tel Aviv Sourasky Medical Center, Tel Aviv

Sponsors

Lead Sponsor

Mitralix
All Listed Sponsors
lead

Mitralix

INDUSTRY